Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT06566261
ABA-101 in Participants With Progressive Multiple Sclerosis
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 11, 2024
Completion: Feb 28, 2027